GO
Loading...

Gilead Sciences Inc

More

  • April 25- Bristol-Myers Squibb Co said its experimental drug cured hepatitis C in over 90 percent of patients in combination with Gilead Sciences Inc's Sovaldi and a commonly prescribed drug, ribavirin, in a late-stage study. Bristol-Myers has been testing the drug, daclatasvir, in combination with Sovaldi after shelving plans to market another hepatitis C...

  • Final Glance: Biotechnology companies Friday, 24 Apr 2015 | 8:08 PM ET

    Amgen Inc. fell $1.26 or. 7 percent, to $167.91. Biogen Idec fell $28.57 or 6.6 percent, to $401.71. Celgene Corp. rose $2.62 or 2.3 percent, to $118.71.

  • NEW YORK, April 24- Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector. Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co,...

  • Midday Glance: Biotechnology companies Friday, 24 Apr 2015 | 1:36 PM ET

    Amgen Inc. fell $1.01 or. 6 percent, to $168.16. Biogen Idec fell $25.40 or 5.9 percent, to $404.88. Celgene Corp. rose $3.05 or 2.6 percent, to $119.14.

  • Early Glance: Biotechnology companies Friday, 24 Apr 2015 | 10:55 AM ET

    Amgen Inc. fell $1.09 or. 6 percent, to $168.08. Biogen Idec fell $26.23 or 6.1 percent, to $404.05. Celgene Corp. rose$. 79 or. 7 percent, to $116.88.

  • April 24- European health regulators warned on Friday against using Gilead Sciences Inc's and Bristol-Myers Squibb Co's hepatitis C medicines along with amiodarone, a drug used to regulate the heartbeat of people with heart rhythm disorders. The European Medicines Agency said there is a risk of severe bradycardia, or heart block, when Gilead's drug Harvoni...

  • Final Glance: Biotechnology companies Thursday, 23 Apr 2015 | 6:05 PM ET

    Amgen Inc. rose$. 07 or percent, to $169.17. Biogen Idec rose $6.71 or 1.6 percent, to $430.28. Celgene Corp. rose$. 55 or. 5 percent, to $116.09.

  • Midday Glance: Biotechnology companies Thursday, 23 Apr 2015 | 1:24 PM ET

    Amgen Inc. fell$. 81 or. 5 percent, to $168.29. Biogen Idec rose $5.95 or 1.4 percent, to $429.52. Celgene Corp. rose$. 39 or. 3 percent, to $115.93.

  • Early Glance: Biotechnology companies Thursday, 23 Apr 2015 | 11:02 AM ET

    Amgen Inc. fell $1.85 or 1.1 percent, to $167.25. Biogen Idec fell $1.23 or. 3 percent, to $422.34. Celgene Corp. fell$. 19 or. 2 percent, to $115.35.

  • That has focused attention on other AbbVie drugs with blockbuster potential, including Viekira Pak, a new hepatitis C medication approved in the U.S. in December. But U.S. sales of $138 million in the first quarter came in below expectations of $215 million, on average, according to survey figures cited by analyst Robyn Karnauskas of Deutsche Bank.

  • Final Glance: Biotechnology companies Wednesday, 22 Apr 2015 | 6:13 PM ET

    Amgen Inc. rose$. 64 or. 4 percent, to $169.10. Biogen Idec rose $1.46 or. 3 percent, to $423.57. Celgene Corp. rose$. 72 or. 6 percent, to $115.54.

  • Midday Glance: Biotechnology companies Wednesday, 22 Apr 2015 | 1:39 PM ET

    Amgen Inc. rose$. 63 or. 4 percent, to $169.09. Biogen Idec fell $1.52 or. 4 percent, to $420.59. Celgene Corp. rose$. 36 or. 3 percent, to $115.18.

  • Early Glance: Biotechnology companies Wednesday, 22 Apr 2015 | 10:25 AM ET

    Amgen Inc. rose$. 66 or. 4 percent, to $169.12. Biogen Idec rose $2.39 or. 6 percent, to $424.50. Celgene Corp. rose $1.08 or. 9 percent, to $115.90.

  • Final Glance: Biotechnology companies Tuesday, 21 Apr 2015 | 6:03 PM ET

    Amgen Inc. rose $2.49 or 1.5 percent, to $168.46. Biogen Idec fell$. 81 or. 2 percent, to $422.11. Celgene Corp. rose$. 07 or. 1 percent, to $114.82.

  • Midday Glance: Biotechnology companies Tuesday, 21 Apr 2015 | 1:45 PM ET

    Amgen Inc. rose $1.98 or 1.2 percent, to $167.95. Biogen Idec fell$. 40 or. 1 percent, to $422.52. Celgene Corp. rose$. 22 or. 2 percent, to $114.97.

  • Most active Nasdaq-traded stocks Tuesday, 21 Apr 2015 | 1:45 PM ET

    Advanced Micro Devices Inc. fell 5.6 percent to $2.35 with 31,084,000 shares traded. Apple Inc. fell. 5 percent to $126.91 with 31,622,700 shares traded. Biocept Inc. fell 6.8 percent to $3.13 with 20,095,800 shares traded.

  • Early Glance: Biotechnology companies Tuesday, 21 Apr 2015 | 10:51 AM ET

    Amgen Inc. rose $2.26 or 1.4 percent, to $168.23. Biogen Idec rose $2.50 or. 6 percent, to $425.42. Celgene Corp. rose $1.17 or 1.0 percent, to $115.92.

  • Final Glance: Biotechnology companies Monday, 20 Apr 2015 | 7:10 PM ET

    Amgen Inc. rose $2.39 or 1.5 percent, to $165.97. Biogen Idec rose $3.48 or. 8 percent, to $422.92. Celgene Corp. rose $1.28 or 1.1 percent, to $114.75.

  • Midday Glance: Biotechnology companies Monday, 20 Apr 2015 | 1:17 PM ET

    Amgen Inc. rose $1.43 or. 9 percent, to $165.01. Biogen Idec rose $3.07 or. 7 percent, to $422.51. Celgene Corp. rose$. 76 or. 7 percent, to $114.23.

  • Early Glance: Biotechnology companies Monday, 20 Apr 2015 | 10:38 AM ET

    Amgen Inc. rose $1.18 or. 7 percent, to $164.77. Biogen Idec rose $2.38 or. 6 percent, to $421.82. Celgene Corp. rose$. 53 or. 5 percent, to $114.00.